相似文献
1
Enhancement of delayed hypersensitivity reaction with varieties of anti-cancer drugs. A common biological phenomenon.
J Exp Med. 1981 Jul 1;154(1):204-9. doi: 10.1084/jem.154.1.204.
2
Local administration of various cytostatic drugs after subcutaneous immunization enhances delayed-type hypersensitivity reaction to sheep red blood cells in mice.
Scand J Immunol. 1986 May;23(5):605-9. doi: 10.1111/j.1365-3083.1986.tb01994.x.
3
Chemotherapy of ovarian cancer.
Int Surg. 1967 Apr;47(4):398-401.
4
When to use cytotoxic drugs in rheumatoid arthritis.
Geriatrics. 1973 Jun;28(6):103-6.
5
[Characteristics of growth and sensitivity to cytostatics of Walker 256 carcinosarcoma in randombred and Wistar rats].
Eksp Med Morfol. 1974;13(4):237-42.
6
[Chemotherapy of solid tumors].
Union Med Can. 1970 Jun;99(6):1042-4.
7
[Therapy of lymphogranulomatosis].
Dtsch Med Wochenschr. 1969 Mar 28;94(13):664-6.
8
The chemical therapy of breast cancer.
Semin Oncol. 1974 Jun;1(2):131-44.
9
[Treatment of disseminated sarcomas of the soft tissues].
Vopr Onkol. 1973;19(7):72-81.
10
[Principles of current chemotherapy of lymphocytic leukemia (review of the literature)].
Vrach Delo. 1979 Jan(1):36-41.
引用本文的文献
1
2
Multi-institutional randomized clinical study on the comparative effects of intracavital chemotherapy alone versus immunotherapy alone versus immunochemotherapy for malignant effusion.
Br J Cancer. 1999 May;80(5-6):775-85. doi: 10.1038/sj.bjc.6690421.
3
Preservation of immune effector cell function following administration of a dose-intense 5-fluorouracil-chemotherapy regimen.
Cancer Immunol Immunother. 1993;36(3):185-90. doi: 10.1007/BF01741090.
4
Host defence mechanisms, antibiotics and immunosuppressive agents--a complex relationship.
Eur J Clin Microbiol. 1984 Aug;3(4):285-7. doi: 10.1007/BF01977474.
5
Local administration of cytostatic drug 4-hydroperoxy-cyclophosphamide (4-HPCY) facilitates cell-mediated immune reactions.
Clin Exp Immunol. 1984 Oct;58(1):161-6.
6
Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells.
J Exp Med. 1982 Apr 1;155(4):1063-74. doi: 10.1084/jem.155.4.1063.
7
Evaluation of various cytostatic drugs as local immunotherapeutic agents.
Invest New Drugs. 1984;2(2):221-5. doi: 10.1007/BF00232355.
8
Modulation of antitumor immunity--immunobiologic approaches.
Springer Semin Immunopathol. 1982;5(2):193-220. doi: 10.1007/BF00199796.
9
Induction of activated macrophages by intraperitoneal injection of mitomycin C in mice.
Cancer Immunol Immunother. 1985;20(2):145-50. doi: 10.1007/BF00205681.
10
Cyclosporin A prevents suppression of delayed-type hypersensitivity in mice immunized with high-dose sheep erythrocytes.
Immunology. 1987 Mar;60(3):409-14.
本文引用的文献
1
Effect of cyclophosphamide on mice bearing methylcholanthrene-induced fibrosarcomas.
Cancer Res. 1980 Aug;40(8 Pt 1):2756-61.
2
Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo.
J Natl Cancer Inst. 1966 Aug;37(2):233-45.
3
Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide.
J Exp Med. 1974 Jun 1;139(6):1529-39. doi: 10.1084/jem.139.6.1529.
4
Functional aspects of the selective depletion of lymphoid tissue by cyclophosphamide.
Immunology. 1972 Oct;23(4):493-501.
5
Phase I study of high doses of methotrexate with citrovorum factor in patients with lung cancer.
Cancer. 1972 Jul;30(1):22-30. doi: 10.1002/1097-0142(197207)30:1<22::aid-cncr2820300105>3.0.co;2-b.
6
Comparative effects of selected cytotoxic agents on transplanted hematopoietic cells.
Transplantation. 1972 Sep;14(3):347-51. doi: 10.1097/00007890-197209000-00010.
7
Preferential development by mice of delayed hypersensitivity to purified basic proteins.
J Allergy. 1968 Sep;42(3):140-56. doi: 10.1016/0021-8707(68)90087-7.
8
Combination cancer therapy: Presidential address.
Cancer Res. 1972 Dec;32(12):2593-607.
9
The rationale for multiple drug chemotherapy in the treatment of osteogenic sarcoma.
Cancer. 1975 Mar;35(3 suppl):936-45. doi: 10.1002/1097-0142(197503)35:3+<936::aid-cncr2820350714>3.0.co;2-b.
10
Clinical response and plasma levels of 5-fluorouracil in patients with colonic cancer treated by drug infusion.
Br J Cancer. 1978 Dec;38(6):719-24. doi: 10.1038/bjc.1978.278.
Zotero 插件